What Next: TBD Plus What Next: TBD Plus

How Hormones Took Over Your Feed

Oct 16, 2026 · 24m

Summary

Wired senior writer Kate Nibbs joins Lizzie O’Leary to explore the explosive growth of the perimenopause industry, driven by telehealth startups and a cultural shift toward hormone therapy. The episode examines how the flawed Women’s Health Initiative study and the rise of GLP-1s created a "perfect storm" for VC-funded companies like Midi and Hims to market HRT online. Nibbs discusses the tension between improved accessibility for ignored patients and concerns over predatory "pill vending machine" models, lack of continuity of care, and the politicized disconnect between pro-hormone advocac…

Topics discussed

Host shares her perimenopause-focused social media feed The explosive growth of the perimenopause industry Defining perimenopause and its diffuse symptoms The legacy of the 2002 Women's Health Initiative study Recent shifts in medical guidelines and the GLP-1 boom Frustrations with traditional healthcare providers Major players in the telehealth hormone market Why middle-aged women are a prime target for wellness tech Concerns about overcorrection and questionable tactics Risks of asynchronous prescribing and 'pill vending machines' The strange bedfellows: MAHA and evidence-based clinicians The political contradiction of hormone therapy advocacy The future of commercialized, a-la-carte healthcare Closing remarks and show credits
Listen ad-free on Castria